Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study.
Jung-Yun LeeJung-Yun LeeMin Soo ChoEun Ji NamSang-Wun KimSunghoon KimYoung-Tae KimPublished in: Journal of gynecologic oncology (2018)
According to our study protocol, IDS followed by paclitaxel-based HIPEC as a first-line treatment appears to be feasible and safe for the treatment of advanced-stage ovarian cancer. Further evaluations of this procedure are required to assess its survival benefits.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- minimally invasive
- randomized controlled trial
- study protocol
- lymph node
- sentinel lymph node
- rectal cancer
- squamous cell carcinoma
- radiation therapy
- chemotherapy induced
- coronary artery bypass
- clinical trial
- open label
- combination therapy
- surgical site infection
- coronary artery disease
- newly diagnosed
- double blind
- placebo controlled